Clinical Evaluation And Cost Analysis Of A Trioplex Real-Time Pcr Assay For The Detection And Differentiation Of Herpes Simplex Virus 1 And 2 In Cutaneous And Mucocutaneous Lesions

Jose Navidad,Beth Pfotenhauer,Noah Leigh,Eric Maas,Steve Gradus,Sanjib Bhattacharyya
DOI: https://doi.org/10.1099/jmm.0.000971
2019-01-01
Journal of Medical Microbiology
Abstract:Purpose. Herpes simplex virus (HSV) is a common lifelong sexually transmitted infection. HSV-1 typically manifests as oral cold sores, while HSV-2 is more traditionally associated with sexual transmission and infection. We have developed a real-time PCR (Trioplex) for the simultaneous detection of HSV-1 and -2 and the bacterial phage internal control (IC) MS2.Methodology. To determine the performance of the Trioplex method and resolve discrepancies, 178 clinical specimens from cutaneous and mucocutaneous sources were tested using 3 different methods; virus culture with direct fluorescent antibody (DFA) immunostaining, Trioplex and a commercially available HSV analyte-specific reagent (ASR).Results. HSV Trioplex was significantly more sensitive than virus culture (89 and 67 % HSV 1/2, respectively) and comparable to the commercial assay (P< 0.001). Cost analysis revealed that the Trioplex reduced cost by 80 % compared to cell culture.Conclusions. The implementation of the HSV Trioplex improved the detection turnaround time from 3-10 days to 2.5 h, thus streamlining Herpes detection, improving sensitivity and reducing laboratory costs.
What problem does this paper attempt to address?